Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-7-1
pubmed:abstractText
To determine the efficacy and safety of budesonide delivered by an inhalation-driven dry powder inhaler (Turbuhaler) in children with moderate to severe persistent asthma.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-3476
pubmed:author
pubmed:issnType
Print
pubmed:volume
132
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
976-82
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9627589-Administration, Inhalation, pubmed-meshheading:9627589-Administration, Topical, pubmed-meshheading:9627589-Adolescent, pubmed-meshheading:9627589-Anti-Inflammatory Agents, pubmed-meshheading:9627589-Asthma, pubmed-meshheading:9627589-Bronchodilator Agents, pubmed-meshheading:9627589-Budesonide, pubmed-meshheading:9627589-Child, pubmed-meshheading:9627589-Dose-Response Relationship, Drug, pubmed-meshheading:9627589-Double-Blind Method, pubmed-meshheading:9627589-Drug Administration Schedule, pubmed-meshheading:9627589-Female, pubmed-meshheading:9627589-Forced Expiratory Volume, pubmed-meshheading:9627589-Humans, pubmed-meshheading:9627589-Hydrocortisone, pubmed-meshheading:9627589-Male, pubmed-meshheading:9627589-Nebulizers and Vaporizers, pubmed-meshheading:9627589-Peak Expiratory Flow Rate, pubmed-meshheading:9627589-Powders
pubmed:year
1998
pubmed:articleTitle
Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
pubmed:affiliation
Carolina Allergy and Asthma Consultants, Raleigh, North Carolina, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study